Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4786892
Max Phase: Preclinical
Molecular Formula: C17H17F3N4O3
Molecular Weight: 382.34
Molecule Type: Unknown
Associated Items:
ID: ALA4786892
Max Phase: Preclinical
Molecular Formula: C17H17F3N4O3
Molecular Weight: 382.34
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1cc(C(=O)O)nc(N2CCC(COc3cnccc3C(F)(F)F)C2)n1
Standard InChI: InChI=1S/C17H17F3N4O3/c1-10-6-13(15(25)26)23-16(22-10)24-5-3-11(8-24)9-27-14-7-21-4-2-12(14)17(18,19)20/h2,4,6-7,11H,3,5,8-9H2,1H3,(H,25,26)
Standard InChI Key: IEDPGHAEGUTECC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 382.34 | Molecular Weight (Monoisotopic): 382.1253 | AlogP: 2.80 | #Rotatable Bonds: 5 |
Polar Surface Area: 88.44 | Molecular Species: ACID | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 1.55 | CX Basic pKa: 5.90 | CX LogP: 0.73 | CX LogD: -0.52 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.85 | Np Likeness Score: -1.42 |
1. Cioffi CL,Muthuraman P,Raja A,Varadi A,Racz B,Petrukhin K. (2020) Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities., 63 (19): [PMID:32878437] [10.1021/acs.jmedchem.0c00996] |
Source(1):